Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In human embryonic kidney cells over‐expressing the human vanilloid receptor type 1 (VR1), palmitoylethanolamide (PEA, 0.5–10 μM) enhanced the effect of arachidonoylethanolamide (AEA, 50 nM) on the VR1‐mediated increase of the intracellular Ca2+ concentration. PEA (5 μM) decreased the AEA half‐maximal concentration for this effect from 0.44 to 0.22 μM. The PEA effect was not due to inhibition of AEA hydrolysis or adhesion to non‐specific sites, since bovine serum albumin (0.01–0.25%) potently inhibited AEA activity, and PEA also enhanced the effect of low concentrations of the VR1 agonists resiniferatoxin and capsaicin. PEA (5 μM) enhanced the affinity of AEA for VR1 receptors as assessed in specific binding assays. These data suggest that PEA might be an endogenous enhancer of VR1‐mediated AEA actions.

Original publication




Journal article


FEBS Letters



Publication Date





253 - 256